Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

11 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
[Treatment of acute lymphoblastic leukemia in adults with seven-drug induction therapy and intensive consolidation with or without autologous stem cell transplantation followed by maintenance therapy. Experience of a single center].
Doubek M, Mayer J, Korístek Z, Protivánková M, Brychtová Y, Oborilová A, Král Z, Klabusay M, Tomíska M, Buchtová I, Vorlícek J. Doubek M, et al. Among authors: protivankova m. Cas Lek Cesk. 2002 Mar 1;141(4):122-6. Cas Lek Cesk. 2002. PMID: 12046256 Czech.
HOTAIR long non-coding RNA is a negative prognostic factor not only in primary tumors, but also in the blood of colorectal cancer patients.
Svoboda M, Slyskova J, Schneiderova M, Makovicky P, Bielik L, Levy M, Lipska L, Hemmelova B, Kala Z, Protivankova M, Vycital O, Liska V, Schwarzova L, Vodickova L, Vodicka P. Svoboda M, et al. Among authors: protivankova m. Carcinogenesis. 2014 Jul;35(7):1510-5. doi: 10.1093/carcin/bgu055. Epub 2014 Feb 28. Carcinogenesis. 2014. PMID: 24583926
Predicting Vitality Change in Older Breast Cancer Survivors after Primary Treatment--an Approach Based on Using Time-related Difference of Pro-inflammatory Marker C-reactive Protein.
Skrivanova K, Anderkova L, Brancikova D, Jarkovský J, Benesova K, Elfmarková N, Svěrák T, Bendová M, Peterkova H, Nedvěd J, Protivánková M, Minar L, Holoubková E, Dusek L. Skrivanova K, et al. Among authors: protivankova m. Klin Onkol. 2016;29(1):52-8. doi: 10.14735/amko201652. Klin Onkol. 2016. PMID: 26879063
Change in Quality of Life Measured over Time in Czech Women with Breast Cancer.
Anderkova L, Elfmarková N, Svěrák T, Peterkova H, Brancikova D, Bendová M, Protivánková M, Benesova K, Dusek L, Jarkovský J, Minar L, Skrivanova K. Anderkova L, et al. Among authors: protivankova m. Klin Onkol. 2016;29(2):113-21. doi: 10.14735/amko2016113. Klin Onkol. 2016. PMID: 27081801
Predictors of quality of life in Czech female breast cancer survivors following treatment with special interest to coping strategies.
Jarkovský J, Skřivanová K, Benešová K, Šnajdrová L, Gregor J, Peterková H, Bendová M, Brančíková D, Elfmarková N, Svěrák T, Anderková Ľ, Minář L, Protivánková M, Nedvěd J, Dušek L, Temoshok L. Jarkovský J, et al. Among authors: protivankova m. Vnitr Lek. 2017 Summer;63(6):389-396. Vnitr Lek. 2017. PMID: 28840734 English.
11 results